GSK3B and heart failure: In a guinea pig model of heart failure, the S-nitrosylation levels of GSK-3β increased as the disease progressed, with S-nitrosylation-mediated inhibition eventually surpassing phosphorylation-induced activation of GSK-3β in the final stages [57].